Every SEC Form 3/4/5 on record for this filer (CIK 1760582) — 3 issuers, 9 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| NVNO | enVVeno Medical Corp | Director | 2021-12-02 → 2026-06-12 | 11 | $288,703 |
| HJLI | Hancock Jaffe Laboratories, Inc. | Director · lapsed | 2018-12-04 → 2021-05-19 | 4 | $50,592 |
| HJIL | Hancock Jaffe Laboratories, Inc. | Director · lapsed | 2018-12-04 → 2018-12-04 | 1 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| NVNO | 2026-06-11 | Sell | 140 | $10.31 | $1,443 | 2,362 |
| NVNO | 2026-03-12 | Sell | 140 | $11.52 | $1,613 | 2,502 |
| NVNO | 2025-12-11 | Sell | 4,900 | $0.36 | $1,764 | 92,544 |
| NVNO | 2025-09-15 | Sell | 4,900 | $0.83 | $4,067 | 97,444 |
| NVNO | 2024-12-31 | Buy | 81,433 | $3.07 | $249,999 | 102,344 |
| NVNO | 2022-08-16 | Buy | 7,751 | $6.14 | $47,591 | 20,911 |
| HJLI | 2021-05-17 | Buy | 9,492 | $5.33 | $50,592 | 13,160 |
1 of 3 issuers are covered and open a security page; the rest are on file here only.
